These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


870 related items for PubMed ID: 9111517

  • 1. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P.
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [Abstract] [Full Text] [Related]

  • 2. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM.
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [Abstract] [Full Text] [Related]

  • 3. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C, Luddy C, Abounader R, Lal B, Laterra J.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):287-93. PubMed ID: 10873600
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4578-85. PubMed ID: 14555533
    [Abstract] [Full Text] [Related]

  • 5. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF.
    Cancer Res; 1997 Dec 01; 57(23):5391-8. PubMed ID: 9393765
    [Abstract] [Full Text] [Related]

  • 6. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
    Koga K, Todaka T, Morioka M, Hamada J, Kai Y, Yano S, Okamura A, Takakura N, Suda T, Ushio Y.
    Cancer Res; 2001 Aug 15; 61(16):6248-54. PubMed ID: 11507079
    [Abstract] [Full Text] [Related]

  • 7. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 8. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM.
    Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618
    [Abstract] [Full Text] [Related]

  • 9. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth.
    Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P.
    Biochem Biophys Res Commun; 1997 Jun 27; 235(3):743-7. PubMed ID: 9207232
    [Abstract] [Full Text] [Related]

  • 10. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 27; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Su Huang HJ, Cavenee WK, Cheng SY.
    Cancer Res; 2001 Dec 01; 61(23):8569-77. PubMed ID: 11731444
    [Abstract] [Full Text] [Related]

  • 13. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM, Hügel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T, Wernert N.
    Cancer Res; 1999 Nov 01; 59(21):5608-14. PubMed ID: 10554042
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y.
    Cancer Gene Ther; 2004 May 01; 11(5):325-32. PubMed ID: 15044958
    [Abstract] [Full Text] [Related]

  • 15. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability.
    Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J.
    Brain Res; 1999 Jul 03; 833(2):173-80. PubMed ID: 10375692
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK.
    Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879
    [Abstract] [Full Text] [Related]

  • 17. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.
    Yamahata H, Takeshima H, Kuratsu J, Sarker KP, Tanioka K, Wakimaru N, Nakata M, Kitajima I, Maruyama I.
    Int J Oncol; 2002 May 28; 20(5):921-8. PubMed ID: 11956584
    [Abstract] [Full Text] [Related]

  • 18. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 28; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 19. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD, Shi YX, Im SA, Chen X, Yung WK.
    Clin Cancer Res; 2000 Jun 28; 6(6):2562-72. PubMed ID: 10873113
    [Abstract] [Full Text] [Related]

  • 20. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.
    Ke LD, Shi YX, Yung WK.
    Cancer Res; 2002 Mar 15; 62(6):1854-61. PubMed ID: 11912165
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.